Does ROSUVASTATIN Cause Ejection fraction decreased? 189 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 189 reports of Ejection fraction decreased have been filed in association with ROSUVASTATIN (Rosuvastatin Calcium). This represents 0.5% of all adverse event reports for ROSUVASTATIN.
189
Reports of Ejection fraction decreased with ROSUVASTATIN
0.5%
of all ROSUVASTATIN reports
8
Deaths
116
Hospitalizations
How Dangerous Is Ejection fraction decreased From ROSUVASTATIN?
Of the 189 reports, 8 (4.2%) resulted in death, 116 (61.4%) required hospitalization, and 4 (2.1%) were considered life-threatening.
Is Ejection fraction decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROSUVASTATIN. However, 189 reports have been filed with the FAERS database.
What Other Side Effects Does ROSUVASTATIN Cause?
Myalgia (3,958)
Dyspnoea (2,832)
Pain (2,758)
Drug ineffective (2,347)
Fatigue (2,208)
Rhabdomyolysis (2,173)
Arthralgia (1,879)
Asthma (1,843)
Muscle spasms (1,843)
Pain in extremity (1,686)
What Other Drugs Cause Ejection fraction decreased?
SACUBITRIL\VALSARTAN (2,551)
TRASTUZUMAB (1,579)
DOXORUBICIN (834)
CYCLOPHOSPHAMIDE (754)
PERTUZUMAB (644)
DOCETAXEL (520)
PACLITAXEL (466)
BISOPROLOL (314)
RITUXIMAB (296)
CARVEDILOL (284)
Which ROSUVASTATIN Alternatives Have Lower Ejection fraction decreased Risk?
ROSUVASTATIN vs ROSUVASTATIN\ROSUVASTATIN
ROSUVASTATIN vs ROTIGOTINE
ROSUVASTATIN vs ROXADUSTAT
ROSUVASTATIN vs ROXICODONE
ROSUVASTATIN vs ROXITHROMYCIN